Astrana Health Stock Performance
| ASTH Stock | 44.81 1.56 3.61% |
The firm shows a Beta (market volatility) of 1.16, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Astrana Health will likely underperform. At this point, Astrana Health has a negative expected return of -0.009%. Please make sure to confirm Astrana Health's treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Astrana Health performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Astrana Health has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Astrana Health is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders. ...more
Actual Historical Performance (%)
One Day Return 3.61 | Five Day Return 3.85 | Year To Date Return 15.55 | Ten Year Return 1.1 K | All Time Return 376.7 |
Last Split Factor 1:10 | Last Split Date 2015-04-27 |
1 | Disposition of 11000 shares by Chiang John of Astrana Health at 15.35 subject to Rule 16b-3 | 09/09/2024 |
2 | Disposition of 11000 shares by Kitayama Mitchell W of Astrana Health at 15.35 subject to Rule 16b-3 | 09/10/2024 |
3 | Disposition of 2626 shares by Brandon Sim of Astrana Health at 57.87 subject to Rule 16b-3 | 10/02/2024 |
4 | Acquisition by Marsh Linda of 11000 shares of Astrana Health at 15.35 subject to Rule 16b-3 | 10/03/2024 |
5 | Astrana Health, Inc.s PE Is Still On The Mark Following 25 percent Share Price Bounce | 10/04/2024 |
6 | RadNet Earnings Expected to Grow What to Know Ahead of Next Weeks Release | 11/04/2024 |
7 | Astrana Health Inc Reports Q3 Revenue of 478.7 Million and EPS of 0.33 | 11/07/2024 |
8 | Acquisition by Sim Kenneth T. of 66667 shares of Astrana Health subject to Rule 16b-3 | 11/08/2024 |
9 | Astrana Health Inc Trading Down 4.02 percent on Nov 12 | 11/12/2024 |
10 | Prospect to sell RI medical group to California company | 11/13/2024 |
11 | Astrana Health, Inc.s 33 percent Cheaper Price Remains In Tune With Earnings | 11/18/2024 |
12 | Disposition of 1515 shares by Chiang John of Astrana Health at 18.41 subject to Rule 16b-3 | 11/19/2024 |
13 | Investors Shouldnt Be Too Comfortable With Astrana Healths Earnings | 11/20/2024 |
14 | Disposition of 3409 shares by Kitayama Mitchell W of Astrana Health at 18.41 subject to Rule 16b-3 | 11/22/2024 |
| Begin Period Cash Flow | 288 M |
Astrana |
Astrana Health Relative Risk vs. Return Landscape
If you would invest 4,708 in Astrana Health on September 4, 2024 and sell it today you would lose (227.00) from holding Astrana Health or give up 4.82% of portfolio value over 90 days. Astrana Health is currently does not generate positive expected returns and assumes 3.5749% risk (volatility on return distribution) over the 90 days horizon. In different words, 31% of stocks are less volatile than Astrana, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Astrana Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Astrana Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Astrana Health, and traders can use it to determine the average amount a Astrana Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0025
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ASTH |
Estimated Market Risk
| 3.57 actual daily | 31 69% of assets are more volatile |
Expected Return
| -0.01 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Astrana Health is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Astrana Health by adding Astrana Health to a well-diversified portfolio.
Astrana Health Fundamentals Growth
Astrana Stock prices reflect investors' perceptions of the future prospects and financial health of Astrana Health, and Astrana Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Astrana Stock performance.
| Return On Equity | 0.1 | ||||
| Return On Asset | 0.0449 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.06 % | ||||
| Current Valuation | 2.1 B | ||||
| Shares Outstanding | 45.65 M | ||||
| Price To Book | 2.80 X | ||||
| Price To Sales | 1.19 X | ||||
| Revenue | 1.39 B | ||||
| Gross Profit | 199.48 M | ||||
| EBITDA | 123.69 M | ||||
| Net Income | 57.85 M | ||||
| Total Debt | 321.01 M | ||||
| Book Value Per Share | 14.75 X | ||||
| Cash Flow From Operations | 68.23 M | ||||
| Earnings Per Share | 1.30 X | ||||
| Market Capitalization | 2.05 B | ||||
| Total Asset | 933.36 M | ||||
| Retained Earnings | 243.13 M | ||||
| Working Capital | 242.83 M | ||||
About Astrana Health Performance
By evaluating Astrana Health's fundamental ratios, stakeholders can gain valuable insights into Astrana Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Astrana Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Astrana Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.10 | 0.11 | |
| Return On Capital Employed | 0.12 | 0.12 | |
| Return On Assets | 0.07 | 0.07 | |
| Return On Equity | 0.10 | 0.10 |
Things to note about Astrana Health performance evaluation
Checking the ongoing alerts about Astrana Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Astrana Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Astrana Health generated a negative expected return over the last 90 days | |
| Astrana Health has high historical volatility and very poor performance | |
| Astrana Health is unlikely to experience financial distress in the next 2 years | |
| Astrana Health was previously known as Astrana Health and was traded on NASDAQ Exchange under the symbol AMEH. | |
| About 24.0% of the company shares are held by company insiders | |
| Latest headline from simplywall.st: Disposition of 3409 shares by Kitayama Mitchell W of Astrana Health at 18.41 subject to Rule 16b-3 |
- Analyzing Astrana Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Astrana Health's stock is overvalued or undervalued compared to its peers.
- Examining Astrana Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Astrana Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Astrana Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Astrana Health's stock. These opinions can provide insight into Astrana Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Astrana Stock analysis
When running Astrana Health's price analysis, check to measure Astrana Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Astrana Health is operating at the current time. Most of Astrana Health's value examination focuses on studying past and present price action to predict the probability of Astrana Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Astrana Health's price. Additionally, you may evaluate how the addition of Astrana Health to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |